What does EFung Capital invest in?
EFung Capital invests most often at Series A and Series B (80% of the rounds on record), in sectors such as Health Care, Market Research and Investment Management.

China · Investor
No cheque observed since Oct 2019, after 5 earlier cheques, and the website is dead.
DormantVC firm
5 rounds on record
Mostly Series A and Series B: 80% of its rounds
Every round we can evidence, newest first5 appearances
1 round
1 round
2 rounds
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The latest companies EFung Capital put money into.
EFung Capital invests most often at Series A and Series B (80% of the rounds on record), in sectors such as Health Care, Market Research and Investment Management.
5 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2019.
Its most recent investments on record: Elicio Therapeutics (Series B, Oct 2019), Tactiva Therapeutics (Series A, Dec 2018) and KPB (Series A, Jan 2017).
The median round it joins is $51M.
Rarely, if at all: none of its 5 investments on record names it as the lead.
Most of the companies it backs are in the United States (80%) and Hong Kong SAR China (20%).
It looks quiet: no investment on record since Oct 2019.
EFung Capital is a VC firm based in Shenzhen Shi, China.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it